Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients.AuthorsMorizane, Chigusa; Okusaka, Takuji; Ueno, Hideki; Kondo, Shunsuke; Ikeda, Masafumi; Furuse, Junji; Shinichi, Ohkawa; Nakachi, Kohei; Mitsunaga, Shuichi; Kojima, Yasushi; Suzuki, Eiichiro; Ueno, Makoto; Yamaguchi, TomohiroPublicationCancer Chemotherapy & Pharmacology, 2012, Vol 69, Issue 4, p957ISSN0344-5704Publication typearticleDOI10.1007/s00280-011-1786-6